ANALYSIS: The approval of remdesivir or Veklury® (trade name) by the European Medicines Agency (EMA) is questionable on many levels. The study, which is pivotal to this approval, includes enough bias that a complete new analysis is required. The National Medicines Safety Agency (ANSM) cannot in any… – Lire la suite sur FranceSoir.fr
FranceSoir
– Remdesivir: does the European Medicines Agency endanger our health?
Source: Lire l'article complet de France-Soir
